These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 31517333)
21. Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis. Salvi F; Volpe R; Pastorelli F; Bianchi A; Vella A; Rapezzi C; Mascalchi M J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e212-e214. PubMed ID: 29779881 [TBL] [Abstract][Full Text] [Related]
22. Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation. Björkenheim A; Szabó B; Sztaniszláv ÁJ BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31932463 [TBL] [Abstract][Full Text] [Related]
23. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171 [TBL] [Abstract][Full Text] [Related]
24. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan. Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406 [TBL] [Abstract][Full Text] [Related]
25. [What gnaws at the heart and gets on the nerves]. Kristen AV Internist (Berl); 2018 Nov; 59(11):1208-1213. PubMed ID: 30039176 [TBL] [Abstract][Full Text] [Related]
26. Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations. Nakov R; Sarafov S; Nakov V; Gospodinova M; Ianiro G; Todorov T; Todorova A; Tournev I Medicine (Baltimore); 2020 Mar; 99(11):e19509. PubMed ID: 32176096 [TBL] [Abstract][Full Text] [Related]
27. [Experience with tafamidis in a patient with transthyretin amyloidosis]. Nasonova SN; Zhirov IV; Magomedov MM; Saidova MA; Osmolovskaya YF; Tereschenko SN Kardiologiia; 2020 Jan; 60(3):155-160. PubMed ID: 32375630 [TBL] [Abstract][Full Text] [Related]
28. Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years. Wixner J; Suhr OB; Anan I Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):73-81. PubMed ID: 29073801 [TBL] [Abstract][Full Text] [Related]
29. THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease. Wixner J; Mundayat R; Karayal ON; Anan I; Karling P; Suhr OB; Orphanet J Rare Dis; 2014 Apr; 9():61. PubMed ID: 24767411 [TBL] [Abstract][Full Text] [Related]
30. A descriptive study of transthyretin amyloidosis in a tertiary hospital without a referral unit. Bueno Juana E; Gracia Gutiérrez A; Melero Polo J; Roteta Unceta-Barrenechea A; Andrés Gracia A; Lahuerta Pueyo C; Menao Guillén S; Revilla Martí P; Aibar Arregui MÁ Rev Clin Esp (Barc); 2022 Mar; 222(3):161-168. PubMed ID: 34563487 [TBL] [Abstract][Full Text] [Related]